Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

KRX:019170 Revenue

Shinpoong Pharmaceutical Co.,Ltd had revenue of 63.89B KRW in the quarter ending June 30, 2026, with 8.99% growth. This brings the company's total for the last twelve months to 239.07B, up 6.21% year-over-year. In the year 2025, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 234.68B with 6.15% growth. That makes Shinpoong Pharmaceutical Co.,Ltd the 18,198th largest company in the world by revenue and 936th in South Korea.

• Revenue (ttm): 239.07B
• Revenue Growth: +6.21%
• P/S Ratio: 1.91
• Revenue / Employee: 364.43M
• Employees: 656
• Market Cap: 463.56B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 168.89B 72.0%
• Japan 22.99B 9.8%
• Others 20.70B 8.8%
• Vietnam 16.24B 6.9%
• Myanmar 3.63B 1.5%
• Philippines 2.24B 1.0%

Fiscal year ended Dec 31, 2025 See the full KRX:019170 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	234.68B	13.59B	6.15%
Dec 31, 2024	221.09B	20.87B	10.42%
Dec 31, 2023	200.23B	-9.06B	-4.33%
Dec 31, 2022	209.29B	20.05B	10.60%
Dec 31, 2021	189.24B	-8.51B	-4.31%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error